JPRN-jRCT1030230130
Recruiting
未知
Prospective observational study to evaluate the efficacy of fosnetupitant for long delayed chemotherapy-induced nausea and vomiting in patients recieving platinam-based chemotherapy (LODEC-N) - Long delayed emesis induced by cancer chemotherapy can be suppressed by NK1 receptor antagonist (LODEC-N)
Seiichiro Kuroda0 sites100 target enrollmentJune 12, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Seiichiro Kuroda
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(i) written informed consent to participate in this study
- •(ii) patients undergoing chemotherapy and administered standard antiemetic therapy
- •(iii) age \>18 years
- •(iv) male or female
- •(v) Eastern Cooperative Oncology Group performance status (ECOG PS) of 0\-1
Exclusion Criteria
- •(i) administration of low or minimal emetic risk rejimen
- •(ii) the use of opioids
- •(iii) patients with a history of habitual vomiting
- •(iv) brain metastasis having uncontrollable symptoms
- •(v) current radio therapy (within three months)
- •(vi) administration of chemotherapy within three months before enrolment
- •(vii) experienced nausea and vomiting within one week before enrollment
- •(viii) the current use of antiemetic agents within two week before enrollment
- •(ix) pregnant and lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective observational study to evaluate the effect of supercritical carbon dioxide processed acellular dermal matrix(SC DERM® Recon) in prosthetic breast reconstructioNeoplasmsKCT0008722Asan Medical Center50
Recruiting
Not Applicable
Prospective observational study to evaluate the efficacy of anamorelin on the course of first line chemotherapy in patients with previously-untreated advanced non-small cell lung cancer and cachexia (NEJ050B)on-small cell lung cancerJPRN-UMIN000050878orth East Japan Study Group (NEJSG)135
Completed
Not Applicable
Prospective observational study to evaluate the efficacy and safety of osimertinib by PK/PD/PGx analysisung CancerJPRN-UMIN000029995ational Cancer CEnter200
Completed
Not Applicable
Prospective observational study to evaluate the efficacy and safety of PD-1/PD-L1 antibody by PK/PD/PGx analysis.ung CancerJPRN-UMIN000029994ational Cancer Center Hospital210
Recruiting
Not Applicable
Prospective observational study to evaluate the efficacy and safety of laparoscopic bilateral uterosacropexy with DynaMesh®-CESA and VASA mesh implants in women with pelvic organ prolapseN81.2Incomplete uterovaginal prolapseDRKS00032443Frauenklinik der Universität zu Köln163